There is little to no association between malpractice liability risk and healthcare quality in the United States, according to systematic review results published in JAMA.
The Pennsylvania Supreme Court has agreed to hear a case that could affect what evidence physicians may present in defense during medical malpractice suits.
Because they’re busy looking in different directions, “innocent until proven guilty” and “first, do no harm” don’t always get along.
A new generation of DNA tests that analyze fetal DNA are seen as a safe and reliable godsend for expectant mothers because, according to the manufacturers, they achieve “near-perfect” accuracy.
Ranking or otherwise gauging physician quality isn’t just a way to assign bragging rights — performance metrics can be used to set reimbursement levels, tailor insurance, and identify physicians who are falling behind.
Results showed that the average post-SI incidence rate of harmful events at JMH was 13% lower compared to the 2 pre-SI years on record.
Malpractice liability reform would best be analyzed on a specialty-by-specialty basis.
A recent bill passed in the US House of Representatives proposes a number of changes to malpractice liability rules, including a $250,000 cap on non-economic damages.
Patients who experience inpatient medical injuries express a desire to understand what the hospital did to prevent injury recurrences.
A communication-and-resolution program, in which hospitals and liability insurers communication with patients when adverse events occur, does not lead to higher liability costs.
